fluorouracil has been researched along with icodextrin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobbie, JW | 1 |
| Downes, M; Gilbert, JA; Hosie, KB; Kerr, DJ; Lakin, G; Pemberton, G; Stanley, A; Timms, K; Young, A | 1 |
| Canet Jourdan, C; Eveno, C; Jouvin, I; Kaci, R; Mirshahi, M; Najah, H; Pimpie, C; Pocard, M | 1 |
3 other study(ies) available for fluorouracil and icodextrin
| Article | Year |
|---|---|
New principles, better practices, and clearer perceptions in intraperitoneal chemotherapy: clinical experience using icodextrin 20 as a carrier solution.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Dialysis Solutions; Drug Carriers; Fluorouracil; Glucans; Glucose; Humans; Icodextrin; Infusions, Parenteral; Peritoneal Neoplasms | 1997 |
A pilot study of adjuvant intraperitoneal 5-fluorouracil using 4% icodextrin as a novel carrier solution.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colorectal Neoplasms; Dialysis Solutions; Female; Fluorouracil; Glucans; Glucose; Home Care Services; Humans; Icodextrin; Infusions, Parenteral; Male; Middle Aged; Pilot Projects; Treatment Outcome | 2003 |
Reduction of carcinomatosis risk using icodextrin as a carrier solution of intraperitoneal oxaliplatin chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Survival; Colonic Neoplasms; Dialysis Solutions; Disease Models, Animal; Fluorouracil; Glucans; Glucose; Icodextrin; Infusions, Parenteral; Mice; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms | 2017 |